Unique ID issued by UMIN | UMIN000040857 |
---|---|
Receipt number | R000046651 |
Scientific Title | Efficacy of metformin 1000mg once or twice daily in patients with type 2 diabetes |
Date of disclosure of the study information | 2020/07/01 |
Last modified on | 2022/11/28 18:16:39 |
Efficacy of metformin 1000mg once or twice daily in patients with type 2 diabetes
Efficacy of metformin 1000 mg once or twice daily
Efficacy of metformin 1000mg once or twice daily in patients with type 2 diabetes
Efficacy of metformin 1000 mg once or twice daily
Japan |
Type 2 diabetes
Endocrinology and Metabolism |
Others
NO
We examine the difference in efficacy depending on the administration method of metformin 1000 mg/day.
Safety,Efficacy
Exploratory
Pragmatic
Not applicable
24-hour average blood glucose, fasting blood glucose, SD and CV.
TIR(time in range), TAR(time above range), TBR(time below range), MAGE(mean amplitude of glucose excursion), maximum blood glucose level, minimum blood glucose level and safety.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
NO
NO
NO
No need to know
1
Treatment
Medicine |
We evaluate glycemic dynamics for 14 days with flash glucose monitoring (FGM) in patients with type 2 diabetes receiving 1000 mg/day of metformin.
First half of observation period (Day 1-7): Metformin 1000 mg orally twice daily (after morning and dinner).
Late observation period (Day 8-14): Metformin 1000 mg orally once daily (after breakfast).
20 | years-old | <= |
75 | years-old | >= |
Male and Female
Type 2 diabetes
Administration of metformin 1000 mg/day
eGFR 45ml/min/1.73m2<=
1. Patients with a history of hypersensitivity to metformin components or biguanide drugs
2. Patients with a history of lactic acidosis
3. Patients with severe renal dysfunction or dialysis patients
4. Patients with severe liver dysfunction
5. Patients with severely impaired cardiovascular system or pulmonary function and other patients who are prone to hypoxemia
6. Patients with dehydration or suspected dehydration
7. Excessive alcohol drinkers
8. Patients with severe ketosis, diabetic coma or pre-coma, or type 1 diabetes
9. Patients with severe infection, before and after surgery, and serious trauma
10. Patients with malnutrition, starvation, weakness, pituitary dysfunction, or adrenal insufficiency
11. Pregnant women, women who may be pregnant, or women who are breast-feeding
12.Other cases judged by the investigator to be inappropriate for this study
30
1st name | Tetsuo |
Middle name | |
Last name | Hayakawa |
Tonami general hospital
Department of diabetes mellitus and endocrinology
939-1395
1-61 Shintomi-cho, Tonami, Toyama, 939-1395, Japan
0763-32-3320
thayakawa-endo@umin.ac.jp
1st name | Ken-ichiro |
Middle name | |
Last name | Kato |
Tonami general hospital
Department of diabetes mellitus and endocrinology
939-1395
1-61 Shintomi-cho, Tonami, Toyama, 939-1395, Japan
0763-32-3320
katou-knz@umin.ac.jp
Tonami general hospital
Department of diabetes mellitus and endocrinology
None
Self funding
None
Tonami general hospital Ethics Committee
1-61 Shintomi-cho, Tonami, Toyama, 939-1395, Japan
0763-32-3320
thayakawa-endo@umin.ac.jp
NO
2020 | Year | 07 | Month | 01 | Day |
Unpublished
0
Terminated
2020 | Year | 06 | Month | 01 | Day |
2020 | Year | 06 | Month | 16 | Day |
2020 | Year | 07 | Month | 01 | Day |
2025 | Year | 03 | Month | 31 | Day |
2020 | Year | 06 | Month | 22 | Day |
2022 | Year | 11 | Month | 28 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046651
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |